423 filings
PRE 14A
AVTX
Avalo Therapeutics Inc
Preliminary proxy
7 Jun 24
7:01am
S-3
AVTX
Avalo Therapeutics Inc
Shelf registration
6 Jun 24
4:03pm
8-K/A
AVTX
Avalo Therapeutics Inc
3 Jun 24
Index to Financial Statements
7:20am
8-K
AVTX
Avalo Therapeutics Inc
23 May 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:01pm
10-Q
2024 Q1
AVTX
Avalo Therapeutics Inc
Quarterly report
13 May 24
7:33am
8-K
0ek2g3g1
13 May 24
Avalo Reports First Quarter 2024 Financial Results and Provides Business Updates
7:30am
D
nm2uzp3
9 Apr 24
$199.98 mm in equity / options, sold $130.60 mm, 25 investors
4:58pm
8-K
xww9g4jdwe qekgn
29 Mar 24
Avalo Reports 2023 Financial Results and Provides Business Updates
4:02pm
DEFA14A
4iv3pa4ln7gqu1
28 Mar 24
Additional proxy soliciting materials
6:26am
8-K
48z9g5ht8ay2b3
28 Mar 24
Avalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 Million
6:08am
8-K
8xe2vpxo
31 Jan 24
Other Events
4:01pm
8-K
zt0afnblgqlycqz
28 Dec 23
Avalo Therapeutics Announces 1-for-240 Reverse Stock Split
5:05pm
8-K
1pi9es2410b8rt
20 Dec 23
Submission of Matters to a Vote of Security Holders
4:01pm
DEFA14A
fms249vm3hd9z6 vss
7 Dec 23
Additional proxy soliciting materials
7:02am
8-K
31dqrxv86w8kv8knby
7 Dec 23
Avalo Encourages Stockholders to Vote FOR the Reverse Stock Split
7:01am
8-K
akkvv63fn3yyj
16 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
7:15am
8-K
5cxia2
9 Nov 23
Avalo Reports Third Quarter 2023 Financial Results and Provides Business Updates
7:04am
8-K
amgc6dh7
31 Oct 23
Avalo Completes Divestiture of AVTX-800 Series
7:21am